Skip to main content
    B

    BioCryst Pharmaceuticals Inc (BCRX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.50
    +0.05 (+0.67%)

    Market Cap: $1.96B

    Last updated: Nov 17, 2026 at 4:51 PM ET

    BioCryst Pharmaceuticals Inc (BCRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    BioCryst Pharmaceuticals (BCRX) has a latest price of $7.50 on Nov 17, 2026, 33.2% below its 52-week high of $11.22. Its price rose 5.9% over the past 12 months. The month-end price rose 109.1% over the 10 years through Oct 2026, a compound annual rate of 7.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $16.61 in Feb 2022 and its lowest $2.00 in Oct 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BCRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BCRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.5%, and over 6 months it fell 14.5%. The month-end price rose 54.3% over the 3 years through Oct 2026, a compound annual rate of 15.6%.

    PeriodChange
    1 month-7.1%
    3 months-25.5%
    6 months-14.5%
    12 months+5.9%
    12 months, with dividends+5.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+54.3%+15.6%
    5 years-43.3%-10.7%
    10 years+109.1%+7.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 115.9%, and its weakest was 2019, when it fell 57.2%.

    YearCloseChange
    2026 through Oct 2026$8.47+8.6%
    2025$7.80+3.7%
    2024$7.52+25.5%
    2023$5.99-47.8%
    2022$11.48-17.1%
    2021$13.85+85.9%
    2020$7.45+115.9%
    2019$3.45-57.2%
    2018$8.07+64.4%
    2017$4.91-22.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 8.0% below its 50-day average of $8.15 and 14.9% below its 200-day average of $8.81.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.50
    52-week high$11.22-33.2%
    52-week low$6.23+20.4%
    50-day average$8.15-8.0%
    200-day average$8.81-14.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 46.0%.

    MeasureValue
    1-year beta0.66
    Largest fall, 1 year-32.9%
    Largest fall, 3 years-46.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BCRX

    What is BCRX's 1-year price change?

    BioCryst Pharmaceuticals's price rose 5.9% over the past 12 months. With dividends included, the 12-month total return was 5.9%.

    What is BCRX's 5-year price change?

    BioCryst Pharmaceuticals's month-end price fell 43.3% over the 5 years through Oct 2026, a compound annual decline of 10.7%. These figures leave out dividends.

    What is BCRX's 52-week high and low?

    BioCryst Pharmaceuticals's 52-week high is $11.22 and its 52-week low is $6.23. Its latest price of $7.50 on Nov 17, 2026 is 33.2% below the high.

    What is BCRX's beta?

    BioCryst Pharmaceuticals's 1-year beta against the S&P 500 is 0.66, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.9%.

    Is the BCRX chart free?

    Yes. Advanced Charting for BCRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.